Eli Lilly's $7 billion deal for Kelonia Therapeutics on Monday was just the latest example | Despite the recent “feeding ...

Chimeric antigen receptor T-cell therapy conferred sustained benefit to individuals with high-risk smoldering multiple myeloma, according to phase 2 trial results. All patients who received a single ...

Researchers are advancing in vivo CAR-T cell engineering, which generates therapeutic immune cells directly inside patients, bypassing complex lab manufacturing. This approach could broaden access, ...

Roswell Park Comprehensive Cancer Center has opened a clinical trial to test whether CAR T-cell therapy—successful in some blood cancers—can treat autoimmune diseases like systemic sclerosis, with ...

At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...

A "beautiful" nurse who passed away just 13 days after doctors found a cancerous brain tumour told her eldest daughter on the ...

In 2013, Jeannie was diagnosed with Non-Hodgkin lymphoma and she underwent multiple rounds of chemotherapy, reaching ...

HMP Liverpool sent an email to Forest Bank saying they had "no concerns from a healthcare perspective regarding this transfer ...

The CAR-PRISM trial enrolled patients with high-risk smoldering multiple myeloma as defined by the 20/2/20 model: plasma ...

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma ...

SAN DIEGO - An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy ...

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...